AUPH Q2 2021 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+22727.6% YoY

Gross Profit

$6M95.3% margin

Operating Income

-$47M-712.0% margin

Net Income

-$47M-710.1% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+624.3%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$386M

Total Liabilities

$54M

Stockholders' Equity

$332M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$29,000	+22727.6%
Gross Profit	$6M	$29,000	+21665.5%
Operating Income	-$47M	-$27M	-75.5%
Net Income	-$47M	-$27M	-77.1%

Revenue Segments

Product

$7M100%

License

$29,0000%